1. Home
  2. ZTS vs IQV Comparison

ZTS vs IQV Comparison

Compare ZTS & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zoetis Inc.

ZTS

Zoetis Inc.

HOLD

Current Price

$74.21

Market Cap

31.2B

Sector

Health Care

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$171.51

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZTS
IQV
Founded
1952
1982
Country
United States
United States
Employees
14500
93000
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.2B
28.6B
IPO Year
2012
2013

Fundamental Metrics

Financial Performance
Metric
ZTS
IQV
Price
$74.21
$171.51
Analyst Decision
Buy
Strong Buy
Analyst Count
12
16
Target Price
$154.18
$227.13
AVG Volume (30 Days)
6.8M
1.6M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
1.86%
N/A
EPS Growth
10.05
4.67
EPS
1.42
1.61
Revenue
$9,467,000,000.00
$9,739,000,000.00
Revenue This Year
$5.63
$6.77
Revenue Next Year
$4.77
$5.89
P/E Ratio
$52.94
$106.17
Revenue Growth
2.28
41.60
52 Week Low
$73.98
$134.65
52 Week High
$172.23
$247.05

Technical Indicators

Market Signals
Indicator
ZTS
IQV
Relative Strength Index (RSI) 13.81 51.09
Support Level N/A $159.08
Resistance Level $129.32 $172.80
Average True Range (ATR) 3.46 6.75
MACD -3.83 0.68
Stochastic Oscillator 0.40 60.50

Price Performance

Historical Comparison
ZTS
IQV

About ZTS Zoetis Inc.

Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 35% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 65% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: